Endocrine Abstracts

Introduction: The pathophysiology of metabolic steatopathy remains complex, prompting numerous inquiries to date. While the isolated presence of antinuclear antibodies (ANA) has been reported in this pathology, their prognostic relevance has not been adequately investigated. The objectives of our study were to: - Examine the prevalence of antinuclear antibodies during metabolic steatopathy. - Investigate the prognostic significance of ANA in metabolic steatopathy.<p class=...

Introduction: The coexistence of type 2 diabetes in patients with metabolic steatopathy is quite common due to a shared pathophysiology of the two conditions, primarily centered around insulin resistance. The objective of our study was to investigate the impact of type 2 diabetes on the prognosis of metabolic steatopathy.Patients and Methods: This was a cross-sectional, single-center descriptive study that collected all cases of metabolic steatopathy pre...

Introduction: Overweight is a major prognostic factor in metabolic steatopathy. The Waist-to-Height Ratio (WHtR) has recently been introduced as a clinical marker predictive of cardiovascular complications related to obesity. The objective of our study was to evaluate the performance of this ratio in detecting complications related to metabolic steatopathy (Liver fibrosis and cardiovascular risk).Patients and Methods: This was a prospective, cross-sectio...

Introduction: Metabolic steatopathy is a public health problem, and its therapeutic management remains a challenge primarily relying on lifestyle and dietary measures. The degree of liver fibrosis represents the major prognostic factor for this condition. The objective of this study was to investigate the impact of obesity and android fat distribution on the progression of hepatic fibrosis in metabolic steatopathy.Patients and Methods: We conducted a pro...

Introduction: Liver steatosis currently represents a hepatic manifestation of metabolic syndrome. It occurs more frequently in patients with obesity, and liver biopsy remains the gold standard for the positive diagnosis of this condition. In recent decades, the positive diagnosis of hepatic steatosis has increasingly relied on non-invasive methods such as Controlled Attenuation Parameter (CAP). The objective of this study was to investigate the prevalence of hepatic steatosis ...